Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Snowflake
SNOW
|
+$199M |
| 2 |
Amazon
AMZN
|
+$162M |
| 3 |
Analog Devices
ADI
|
+$104M |
| 4 |
Palantir
PLTR
|
+$94.3M |
| 5 |
Tesla
TSLA
|
+$82.7M |
Top Sells
| 1 |
Apple
AAPL
|
+$350M |
| 2 |
Microsoft
MSFT
|
+$261M |
| 3 |
L3Harris
LHX
|
+$185M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$166M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$135M |
Sector Composition
| 1 | Technology | 27.74% |
| 2 | Healthcare | 14.18% |
| 3 | Consumer Discretionary | 13.57% |
| 4 | Communication Services | 11.55% |
| 5 | Industrials | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
701
MKS Inc. Common Stock
MKSI
$7.43B
| $18.5M | 0.01% |
122,300
+600
| +0.5% | +$90.5K |
|
|
AZPN
702
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $18.4M | 0.01% |
150,200
+700
| +0.5% | +$86K |
|
703
Boston Beer
SAM
$2.39B
| $18.4M | 0.01% |
36,100
-1,000
| -3% | -$510K |
|
704
Churchill Downs
CHDN
$6.77B
| $18.4M | 0.01% |
153,200
+600
| +0.4% | +$72K |
|
705
Organon & Co
OGN
$2.67B
| $18.3M | 0.01% |
559,175
-2,000
| -0.4% | -$65.6K |
|
706
Bruker
BRKR
$4.63B
| $18.3M | 0.01% |
234,400
-1,800
| -0.8% | -$141K |
|
707
United Therapeutics
UTHR
$17.9B
| $18.3M | 0.01% |
98,900
+700
| +0.7% | +$129K |
|
708
Federal Realty Investment Trust
FRT
$8.67B
| $18.2M | 0.01% |
154,600
+2,300
| +2% | +$271K |
|
709
Jabil
JBL
$23.2B
| $18.2M | 0.01% |
312,400
-2,700
| -0.9% | -$158K |
|
710
Intellia Therapeutics
NTLA
$1.21B
| $18.2M | 0.01% |
135,600
+1,200
| +0.9% | +$161K |
|
|
BERY
711
DELISTED
Berry Global Group, Inc.
BERY
| $18.1M | 0.01% |
324,651
+3,050
| +0.9% | +$171K |
|
|
SMAR
712
DELISTED
Smartsheet Inc.
SMAR
| $18M | 0.01% |
261,500
+5,500
| +2% | +$379K |
|
713
Erie Indemnity
ERIE
$17.3B
| $18M | 0.01% |
100,746
-3,200
| -3% | -$571K |
|
|
BHVN
714
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $18M | 0.01% |
129,400
+10,500
| +9% | +$1.46M |
|
715
Altice USA
ATUS
$1.09B
| $18M | 0.01% |
866,480
-82,600
| -9% | -$1.71M |
|
716
APA Corp
APA
$8.33B
| $17.9M | 0.01% |
835,000
+4,000
| +0.5% | +$85.7K |
|
717
Tetra Tech
TTEK
$9.37B
| $17.9M | 0.01% |
598,500
+1,000
| +0.2% | +$29.9K |
|
718
Credicorp
BAP
$21B
| $17.6M | 0.01% |
158,752
-74
| -0% | -$8.21K |
|
719
Gentex
GNTX
$6.15B
| $17.6M | 0.01% |
533,700
-3,400
| -0.6% | -$112K |
|
720
Ciena
CIEN
$18.4B
| $17.6M | 0.01% |
342,500
+500
| +0.1% | +$25.7K |
|
|
PLAN
721
DELISTED
Anaplan, Inc.
PLAN
| $17.5M | 0.01% |
287,500
+6,000
| +2% | +$365K |
|
722
WEX
WEX
$5.81B
| $17.4M | 0.01% |
98,826
+1,600
| +2% | +$282K |
|
723
AGCO
AGCO
$8.02B
| $17.4M | 0.01% |
141,600
+1,300
| +0.9% | +$159K |
|
724
Dick's Sporting Goods
DKS
$20.4B
| $17.3M | 0.01% |
144,800
-100
| -0.1% | -$12K |
|
725
AptarGroup
ATR
$8.98B
| $17.3M | 0.01% |
145,200
+1,600
| +1% | +$191K |
|